| Plasma-generating glucose monitor accuracy demonstrated in an animal model. | |
| | |
MedLine Citation:
|
PMID: 20144396 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
INTRODUCTION: Four randomized controlled trials have compared mortality and morbidity of tight glycemic control versus conventional glucose for intensive care unit (ICU) patients. Two trials showed a positive outcome. However, one single-center trial and a large multicenter trial had negative results. The positive trials used accurate portable lab analyzers. The negative trial allowed the use of meters. The portable analyzer measures in filtered plasma, minimizing the interference effects. OptiScan Biomedical Corporation is developing a continuous glucose monitor using centrifuged plasma and mid-infrared spectroscopy for use in ICU medicine. The OptiScanner draws approximately 0.1 ml of blood every 15 min and creates a centrifuged plasma sample. Internal quality control minimizes sample preparation error. Interference adjustment using this technique has been presented at the Society of Critical Care Medicine in separate studies since 2006. METHOD: A good laboratory practice study was conducted on three Yorkshire pigs using a central venous catheter over 6 h while performing a glucose challenge. Matching Yellow Springs Instrument glucose readings were obtained. RESULTS: Some 95.7% of the predicted values were in the Clarke Error Grid A zone and 4.3% in the B zone. Of those in the B zone, all were within 3.3% of the A zone boundaries. The coefficient of determination (R(2)) was 0.993. The coefficient of variance was 5.02%. Animal necropsy and blood panels demonstrated safety. CONCLUSION: The OptiScanner investigational device performed safely and accurately in an animal model. Human studies using the device will begin soon. |
| | |
Authors:
|
Peggy Magarian; Bernhard Sterling |
Related Documents
:
|
19116416 - Adaptation of a lay health advisor model as a recruitment and retention strategy in a c... 17925316 - Evaluation of networks of randomized trials. 16315646 - Direct likelihood analysis versus simple forms of imputation for missing data in random... 14578246 - Validation of the archimedes diabetes model. 17377266 - A stable cutting method for finite elements based virtual surgery simulation. 20018146 - Are adverse effects incorporated in economic models? an initial review of current pract... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2009-11-01 |
Journal Detail:
|
Title: Journal of diabetes science and technology Volume: 3 ISSN: 1932-2968 ISO Abbreviation: J Diabetes Sci Technol Publication Date: 2009 Nov |
Date Detail:
|
Created Date: 2010-02-10 Completed Date: 2010-09-30 Revised Date: 2013-05-30 |
Medline Journal Info:
|
Nlm Unique ID: 101306166 Medline TA: J Diabetes Sci Technol Country: United States |
Other Details:
|
Languages: eng Pagination: 1411-8 Citation Subset: IM |
Affiliation:
|
OptiScan Biomedical Corporation, Hayward, California 94545, USA. pmagarian@optiscancorp.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Automation Blood Glucose / metabolism* Catheterization, Central Venous / instrumentation Catheters, Indwelling Centrifugation Diagnostic Equipment* Equipment Design Feasibility Studies Materials Testing Models, Animal Monitoring, Physiologic / instrumentation* Phlebotomy / instrumentation Reproducibility of Results Spectrophotometry, Infrared Swine Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin p...
Next Document: A benchtop closed-loop system controlled by a bio-inspired silicon implementation of the pancreatic ...